These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31172516)

  • 21. Phylogenetic classification of protozoa based on the structure of the linker domain in the bifunctional enzyme, dihydrofolate reductase-thymidylate synthase.
    O'Neil RH; Lilien RH; Donald BR; Stroud RM; Anderson AC
    J Biol Chem; 2003 Dec; 278(52):52980-7. PubMed ID: 14555647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
    Sayre PH; Finer-Moore JS; Fritz TA; Biermann D; Gates SB; MacKellar WC; Patel VF; Stroud RM
    J Mol Biol; 2001 Nov; 313(4):813-29. PubMed ID: 11697906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The complex of the anti-cancer therapeutic, BW1843U89, with thymidylate synthase at 2.0 A resolution: implications for a new mode of inhibition.
    Stout TJ; Stroud RM
    Structure; 1996 Jan; 4(1):67-77. PubMed ID: 8805515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural Comparison of
    Pozzi C; Ferrari S; Luciani R; Tassone G; Costi MP; Mangani S
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30935102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and binding mode assessment of N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-γ-glutamyl-D-glutamic acid (BGC 945), a novel thymidylate synthase inhibitor that targets tumor cells.
    Tochowicz A; Dalziel S; Eidam O; O'Connell JD; Griner S; Finer-Moore JS; Stroud RM
    J Med Chem; 2013 Jul; 56(13):5446-55. PubMed ID: 23710599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from cryptosporidium.
    Bolstad DB; Bolstad ES; Frey KM; Wright DL; Anderson AC
    J Med Chem; 2008 Nov; 51(21):6839-52. PubMed ID: 18834108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma brucei dihydrofolate reductase-thymidylate synthase: gene isolation and expression and characterization of the enzyme.
    Gamarro F; Yu PL; Zhao J; Edman U; Greene PJ; Santi D
    Mol Biochem Parasitol; 1995 Jun; 72(1-2):11-22. PubMed ID: 8538681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 2-amino-4-oxo-5-arylthio-substituted-pyrrolo[2,3-d]pyrimidines as nonclassical antifolate inhibitors of thymidylate synthase.
    Gangjee A; Jain HD; Kisliuk RL
    Bioorg Med Chem Lett; 2005 May; 15(9):2225-30. PubMed ID: 15837298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from Cryptosporidium.
    Mukerjee A; Iyidogan P; Castellanos-Gonzalez A; Cisneros JA; Czyzyk D; Ranjan AP; Jorgensen WL; White AC; Vishwanatha JK; Anderson KS
    Bioorg Med Chem Lett; 2015; 25(10):2065-7. PubMed ID: 25900220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemistry. DNA building block reinvented.
    Murzin AG
    Science; 2002 Jul; 297(5578):61-2. PubMed ID: 12029066
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
    Gangjee A; Lin X; Kisliuk RL; McGuire JJ
    J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional identity of the active sites of crustacean and viral thymidylate synthases.
    Arvizu-Flores AA; Aispuro-Hernandez E; Garcia-Orozco KD; Varela-Romero A; Valenzuela-Soto E; Velazquez-Contreras EF; Rojo-Domínguez A; Yepiz-Plascencia G; Maley F; Sotelo-Mundo RR
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Sep; 150(3):406-13. PubMed ID: 19559812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum.
    Vásquez JR; Goozé L; Kim K; Gut J; Petersen C; Nelson RG
    Mol Biochem Parasitol; 1996 Aug; 79(2):153-65. PubMed ID: 8855552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition.
    Costi PM; Rinaldi M; Tondi D; Pecorari P; Barlocco D; Ghelli S; Stroud RM; Santi DV; Stout TJ; Musiu C; Marangiu EM; Pani A; Congiu D; Loi GA; La Colla P
    J Med Chem; 1999 Jun; 42(12):2112-24. PubMed ID: 10377217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based studies on species-specific inhibition of thymidylate synthase.
    Costi MP; Tondi D; Rinaldi M; Barlocco D; Pecorari P; Soragni F; Venturelli A; Stroud RM
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):206-14. PubMed ID: 12084462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3D-QSAR studies on quinazoline antifolate thymidylate synthase inhibitors by CoMFA and CoMSIA models.
    Srivastava V; Gupta SP; Siddiqi MI; Mishra BN
    Eur J Med Chem; 2010 Apr; 45(4):1560-71. PubMed ID: 20153089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Plasmodium knowlesi dihydrofolate reductase-thymidylate synthase and sensitivity to antifolates.
    Ittarat W; Pornthanakasem W; Mungthin M; Suwandittakul N; Leelayoova S; Tarnchompoo B; Yuthavong Y; Kongkasuriyachai D; Leartsakulpanich U
    Parasitol Int; 2018 Dec; 67(6):787-792. PubMed ID: 30114522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2'-Deoxyuridine 5'-monophosphate substrate displacement in thymidylate synthase through 6-hydroxy-2H-naphtho[1,8-bc]furan-2-one derivatives.
    Ferrari S; Calò S; Leone R; Luciani R; Costantino L; Sammak S; Di Pisa F; Pozzi C; Mangani S; Costi MP
    J Med Chem; 2013 Nov; 56(22):9356-60. PubMed ID: 24147825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The structural mechanism for half-the-sites reactivity in an enzyme, thymidylate synthase, involves a relay of changes between subunits.
    Anderson AC; O'Neil RH; DeLano WL; Stroud RM
    Biochemistry; 1999 Oct; 38(42):13829-36. PubMed ID: 10529228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclopenta[g]quinazoline-based antifolates: the effect of the chirality at the 6-position on the inhibition of thymidylate synthase (TS).
    Bavetsias V; Marriott JH; Theti DS; Melin JC; Wilson SC; Jackman AL
    Bioorg Med Chem Lett; 2001 Dec; 11(23):3015-7. PubMed ID: 11714600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.